Early Cervical Cancer Genetic Test is a precise tool for the new generation of abnormal TCT or abnormal Hr-HPV triage by detecting the methylation of cervical cancer-related genes in cervical exfoliated cells to achieve early detection, diagnosis, and treatment for people at high risk of cervical cancer.